摘要 |
This invention provides methods, compounds and compositions for the treatment of musculoskeletal disease, muscle dysfunction, muscle-wasting disease or disorder, including hereditary myopathy, neuromuscular disease, muscular dystrophy, muscular atrophy, drug-induced myopathy, and related disease, disorder or condition that causes a decrease in muscle strength, comprising the use of heterocyclic non-peptidic compounds that act as Mas agonists and/or mimics of angiotensin 1-7. |
申请人 |
University of Southern California |
发明人 |
Gaffney, Kevin J.;Rodgers, Kathleen E.;Louie, Stan G.;Dizerega, Gere S.;Petasis, Nicos A. |